Forssmann Symposium 2019 – 90 Years After the Self-Experiment
Lecture: Interventional Cardiology of the Coronary Arteries (PCI): Yesterday – Today – Tomorrow
Eberswalde, Haus Schwärzetal, November 8, 2019

Expert Discussion Munich Scientific Direction
Munich, Maritim Hotel, October 23, 2019

TCT Congress, San Francisco, California Various Chairmanships and Moderations
September 25 – 29, 2019

48th Conference of the Professional Association of German Nuclear Medicine Specialists (BDN) Nuclear Cardiology From the Heart’s Depths
Lecture: Pharmacological Stress Tests: Experience in a Cardiology Practice
Berlin, Pullman Berlin Schweizerhof, September 20, 2019

14th Course for Cardiovascular Nuclear Medicine / Nuclear Cardiology
Lecture: The New ESC 2019 Guidelines for Management of Chronic Coronary Syndrome (CCS): What Does Invasive Cardiology Need to Know From Nuclear Cardiology?
Potsdam, Inselhotel, September 14, 2019

Annual Meeting of the European Society of Cardiology (ESC)
Lectures:

1. Frail Patient With Coronary Heart Disease
2. Congress Condensed – Coronary Heart Disease

Paris, August 31 and September 4, 2019

15th Zweibrücken Symposium “Left and Right of Cardiology”
Lecture: News and Practice-Relevant Insights From ACC 2019
Nardini Clinic, Zweibrücken, May 25, 2019

85th Annual Meeting of the German Society of Cardiology – Heart and Circulatory Research (DGK) Mannheim, April 24 and 25, 2019

• Lecture by Prof. Silber: Regadenoson for Pharmacological Stress Testing in Myocardial Scintigraphy Program
• Lecture (Keynote Session) M. Keller, P. Styllou, S. Silber: The New US Guidelines for Statin Therapy and Determination of the Coronary Calcium Score in Primary Prevention: An Analysis of Over 12,000 Individuals Program Scientific Abstract
• Chairmanship and Introduction by Prof. Silber: Noninvasive Ischemia Quantification and Viability Detection: What Is Relevant for the Decision on Myocardial Revascularization in Light of the New ESC Guidelines? Program

Spotlight Lipids Munich, Marriott Hotel, March 30, 2019
Interdisciplinary Congress Update ACC: Cross-Indication Outlook on Therapeutic Developments
Program

9th Cardiology Symposium Bad Griesbach, March 23, 2019
Guidelines on Myocardial Revascularization Including Dual Antithrombotic Therapy
Program

68th Annual Meeting of the American College of Cardiology (ACC) New Orleans, March 16, 2019 Poster, S. Silber, M. Rippel, M. Keller:
Regadenoson for Pharmacological Stress Tests: Blood Pressure, Heart Rate and Major Side Effects in 5780 Patients Referred for Myocardial Scintigraphy. A High-Volume Single-Center Experience
Program Abstract Poster

Continuing Education Event Diabetes, CHD and Heart Failure Munich, February 2, 2019 Klinikum Rechts der Isar Lecture by Prof. Silber:
Still High Mortality Rates in Type 1 Diabetes With Early Onset: New Targets for Cardioprotection?
Program

11th pci.live Congress Munich, November 28 – 29, 2018
Program All Presentations

24th Dresden Symposium “Heart and Vessels – Innovations 2018” Dresden, November 24, 2018 Lecture by Prof. Silber:
ESC Guideline on Myocardial Revascularization 2018 – What Is Really New?
Program

“Herztage” of the DGK (German Society of Cardiology) Berlin, October 11 – 13, 2018

• Chairmanship and Introduction: Fundamentals of Imaging Procedures in CHD Diagnostics for the Cardiology Exam (Cluster Imaging Procedures)
• Poster (P. Styllou and S. Silber): Program Scientific Abstract
• Poster: Distribution of Coronary Artery Calcification in a Cardiology Practice Population of Over 13,000 Patients in Germany. Do We Need to Adjust Thresholds for Pharmacological Prevention?

TCT Congress, San Diego, California, USA September 21 – 25, 2018
Various Chairmanships and Lectures (Overview)

• Poster Presentation: Five Year Clinical Outcomes for Resolute Zotarolimus-Eluting Stents in Total Occlusions

19th International Cardiology Symposium – Meet The Experts Düsseldorf, September 15, 2018 Chairmanship and Lecture by Prof. Silber:
Triple Therapy After PCI in AF Patients: An Individualized Decision or Already Obsolete?
Program

European Society of Cardiology (ESC) Munich, August 29, 2018 Lecture by Prof. Silber
Congress Condensed: Coronary Heart Disease
Program

European Society of Cardiology (ESC) Munich, August 25, 2018 Best Poster: M. Keller, M. Rippel, S. Silber:
Side Effects of Regadenoson Replacing Adenosine for Pharmacological Stress Tests in the Real World: Prospective Evaluation in Over 5000 Patients

• Abstract
• Program
• Poster

Practice Anticoagulation Forum Munich, July 14, 2018 Scientific Leadership
Program

Rosenheim Cardiology Days Rosenheim, June 30, 2018 Lecture by Prof. Silber
CHD in Atrial Fibrillation: Is Triple Therapy After Stent Implantation Obsolete?
Program

“Great Minds” European PCI Expert Meeting Vienna, June 15, 2018 Lecture by Prof. Silber:
Short DAPT Case
Program

May Continuing Education 2018 Altötting, May 2, 2018 Medical Clinics of the District Hospitals Altötting-Burghausen Lecture by Prof. Silber:
Atrial Fibrillation and Coronary Stents: End of Triple Therapy? DAPT How Long?
Program

German Society of Internal Medicine (DGIM) Mannheim, April 16, 2018 Chairmanship and Discussion by Prof. Silber:
Lipid Management Solved? PCSK9 Inhibitors – A Sustainable Approach in Secondary Prevention
Program Press Report

Annual Meeting of the German Society of Cardiology (DGK) Mannheim, April 4, 2018 Lecture by Prof. Silber:
Imaging Prior to Atrial Fibrillation Ablation – What Is Established, What Is New, What Is Obsolete? Introduction to the Topic
Program Cluster “Imaging Procedures”

American College of Cardiology (ACC) Orlando, March 11, 2018
IMPACT OF PERIPROCEDURAL MYOCARDIAL BIOMARKER ELEVATION ON MORTALITY FOLLOWING PERCUTANEOUS CORONARY INTERVENTION: A POOLED PATIENT-LEVEL (N=13452) ANALYSIS OF CONTEMPORARY STENT TRIALS JACC March 20, 2018 Volume 71, Issue 11
Abstract Poster

10th German Cardio Diagnostics Days Leipzig, February 23, 2018 Congress Hall Lecture by Prof. Silber:
Regadenoson in Ischemia Diagnostics – Experience in Over 5000 Patients in a Cardiology Practice
Program

8th Cardiology Symposium Bad Griesbach, March 3, 2018 Lecture by Prof. Silber:
Dual Therapy or Triple Therapy After Coronary Stent Implantation?
Program

18th Annual Meeting of NFIC (New Frontiers in Interventional Cardiology) Krakow, December 7 and 8, 2017 Chairmanships and Lecture by Prof. Silber:
Usefulness of Pharmacological Stress Tests With Regadenoson: Experience in Over 4000 Patients in a Cardiology Practice in Germany.
Program Letter of Appreciation

Cardiology Training Seminars Schloss Wilhelminenberg (Vienna), December 2, 2017 Lecture by Prof. Silber:
Does the Coronary Calcium Score Provide Additional Information to Estimate Cardiac Risk?
Program

10th pci-live Congress, Haus der Kunst, Munich November 30 and December 1, 2017 Lectures by Prof. Silber:

• Is Triple Therapy Obsolete?
• Latest TCT Studies on DAPT Duration After Stent Implantation/ACS: Are the ESC DAPT Guidelines of August 2017 Already Outdated?

Program

Annual Meeting of CIAT (Cardiovascular Intervention Association of Thailand) Bangkok, November 18, 2017 Lecture by Prof. Silber:
Should All DAPTs Post PCI Be New P2Y12?
Program

TCT Congress, Denver, Colorado October 29 – November 2, 2017 Chairmanships and Lecture by Prof. Silber:
Promus Element Everolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective
Program

Heart Failure Roundtable Berlin, October 12, 2017 Chairmanship and Lecture by Prof. Silber:
Heart Failure – Introduction to the Topic
Program

Current Developments in Cardiology Düsseldorf, September 23, 2017 Chairmanship and Lecture by Prof. Silber:
Secondary Prevention After ACS With Antiplatelet Agents in the Long Term (1–4 Years); How Would You Decide? Interactive Case Discussion
Program

Annual Meeting of the European Society of Cardiology (ESC) Barcelona, August 30, 2017 Lecture by Prof. Silber:
Congress Condensed – General Cardiology Coronary Artery Disease
Program

Munich Medical Day Clinic and Polyclinic for Psychiatry and Psychotherapy, Lecture Hall 124 Nußbaumstr. 7 Munich, September 16, 2017 Lecture by Prof. Silber:
Antiplatelet Therapy in CHD: What Must the General Practitioner Know From the Current Data Jungle?
Program

Munich Heart Congress Munich, Literaturhaus, September 16, 2017 Panel and Lecture by Prof. Silber:
Antiplatelet Therapy After Coronary Stent Implantation: With What? How Long? Are Bare Metal Stents Still Indicated? Is Triple Therapy Obsolete?
Program

Cardio-Workshop Munich, July 5, 2017 Scientific Direction and Lecture by Prof. Silber:
Scientific Basics and Updates in the Therapy of Acute Coronary Syndrome: Dual Antiplatelet Therapy in High-Risk Patients Beyond 12 Months?
Program

Practice Anticoagulation Forum Munich, July 1, 2017 Scientific Direction: Prof. Silber
Program

Hyperlipidemia Update Munich, June 28, 2017 Scientific Direction: Prof. Silber
Program

Great Minds – Expert Meeting Budapest, June 23, 2017 Lecture by Prof. Silber:
Old and New Effective Strategies for LDL-Cholesterol Reduction
Program Video of the Lecture (In English, Duration: 18:46)

EuroPCR Congress Paris, May 17, 2017 Poster Presentation: Okada K, Cutlip D.E., Barakat M, Silber S, Erglis A, Honda Y on behalf of the COBRA PzF SHIELD Investigators
Final Optical Coherence Tomography Results From the COBRA PzF SHIELD Trial
Poster

International Conference on Nuclear Cardiology and Cardiac CT (ICNC) Vienna, May 9, 2017 Poster Presentation: Dr. med. M. Keller and Prof. Dr. S. Silber:
High Safety of Regadenoson for Myocardial Perfusion Imaging in a Cardiology Practice: Experience in Over 4000 Patients
Poster

123rd Annual Meeting of the German Society of Internal Medicine (DGIM) Mannheim, May 1, 2017 Expert Forum Lecture by Prof. Silber:
Antiplatelet Agents in CHD: Which One? How Long?
Program

DIABETES 2017: Interface of Metabolism and Cardiovascular Risk Munich, Klinikum Rechts der Isar, April 26, 2017 Lecture by Prof. Silber:
Are Antidiabetic Drugs Now “Cardiologic”?
Program

Patient-Centered Anticoagulation in Clinical Practice: Munich, Municon, February 14, 2017 Lecture by Prof. Silber:
Which NOAC for Which Patient?
Program

Heart Failure Bavaria Congress, Würzburg 3rd Network Meeting, January 25, 2017
Lecture by Prof. Silber: The New DMP Heart Failure and HeartCareBavaria
Program

pci-live Congress, Haus der Kunst, Munich December 2, 2016

• Lecture by Prof. Silber: How Much Diabetology Is Needed in Cardiology? (In German, Duration: 13:07)
  • Lecture as PPT file (14 MB)

pci-live Congress, Haus der Kunst, Munich December 1, 2016

• Lecture by Prof. Silber: Secondary Prevention With Extended DAPT (In German, Duration: 17:06)
  • Lecture as PPT file (21 MB)
• Discussion of the Lecture: (In German, Duration: 3:55)

TCT Congress, Washington, DC November 1, 2016
Lecture by Prof. Silber: Didactic Session: The TCT Late Breaking Trials: Highlights – and My Interpretations – From: BIO-RESORT (TWENTE III) and BIONICS (Lecture in Original Sound, in English, Duration: 7:34)

• Lecture as PPT file (8 MB)
• Discussion of the Lecture: (In English, Duration: 12:54)

TCT Congress, Washington, DC October 31, 2016
Lecture by Prof. Silber: Can Passive Coatings Make a Difference? Results With the COBRA PzF NanoCoated Coronary Stent (PPT file, 3.5 MB)
Lecture as Video in English (Duration: 6:45)

Munich Heart 2016
Lecture: Dual Antiplatelet Therapy (DAPT) After Coronary Stent Implantation: With What? How Long Is Optimal – Weeks or Years?
Munich, September 10, 2016

ESC Congress (European Society of Cardiology) Rome, August 2016
Lecture: Nightmares in Clinical Practice: To Stop or Not to Stop Antiaggregation and/or Anticoagulation Before a Procedure Video of the Lecture (In English, Duration: 19:22)
Lecture: Take Home Message for the Practitioner: Coronary Heart Disease Video of the Lecture (In English, Duration: 10:46)
Poster: R. Piccolo, A. Franzone, K. Koskinas, L. Raeber, T. Pilgrim, M. Valgimigli, S. Stortecky, J. Rat-Wirtzler, S. Silber, P. Juni, D. Heg, S. Windecker Diabetes and Time Course of Adverse Events in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

Rosenheim Cardiology Days
Lecture: Therapy of Stable CHD 2016 – Medications vs. Revascularization: The Current National Care Guideline
Rosenheim, July 2, 2016

Case Workshop: Risks in Interventional Cardiology
Lecture: Pitfalls in ACS Patients – Recognition and Treatment
Eberswalde / Werbellinsee, June 22, 2016

Munich Medical Day
Lecture: NOACs – Are There Differences? Summary
Munich, June 18, 2016

Annual Meeting of the German Society of Internal Medicine (DGIM)
Lecture: National Care Guidelines: CHD From the Cardiologist’s View
Mannheim, April 9, 2016

Annual Meeting of the German Society of Cardiology (DGK) J.-N. Boeckel, L. Palapies, J. Klotsche, T. Zeller, B. von Jeisen, L. Pieper, S. Tzikas, D. Leistner, C. Bickel, G. K. Stalla, H. Lehnert, S. Silber, S. Baldus, W. März, S. Dimmeler, S. Blankenberg, T. Münzel, A. M. Zeiher, T. Keller
Lecture: A New Method to Adjust Troponin I Accounting for the Confounders Age, Gender and Kidney Function Facilitates Clinical Interpretation in Patients With Chest Pain
Mannheim, April 2, 2016

Congress: “Diabetology Without Borders”
Lecture: Current Cardiovascular Outcome Studies – Implications for Diabetes Therapy… …From the Cardiologist’s Perspective
Unterschleißheim, February 19, 2016

pci-live Congress, Haus der Kunst, Munich

• Congress Trailer (Duration: 1:00)

1. December 2, 2015 Introduction and Concept, Prof. Silber (in German, Duration: 3:14)
2. December 3, 2015 Lecture Prof. Silber: Real-world use of NOACs: nuances of triple therapy – with what? for how long? (in German, Duration: 25:05)

• Lecture as PPT file (20 MB)

Munich Medical Day
Lecture:Dual antiplatelet therapy in CHD: end of standardized treatment? Chair
Munich, September 26, 2015

Workshop Stroke Prophylaxis in Atrial Fibrillation: Oral Anticoagulants in Transition
Lecture: Overview of current anticoagulants: guideline recommendations
Munich, September 15, 2015

ESC Congress (European Society of Cardiology) Piccolo R, Heg D, Rat, Franzone JA, Silber S, Serruys PW, Pigrim T, Juni P, Windecker S.
Comparative effectiveness and safety of new versus early-generation drug-eluting stents according to the complexity of coronary artery disease: A patient-level pooled analysis of 6,081 patients
download presentation download abstract, European Heart Journal (2015) 36 (Abstract Supplement), 29
London, August 29, 2015

4th National TAVI User Meeting (Certificate of Attendance)
Munich, June 26, 2015

Workshop Medicine and Law: Law and Risks in Interventional Cardiology
Lecture: Pitfalls in Antiplatelet Therapy
Eberswalde, June 12, 2015

Workshop Medicine and Law: Law and Risks in Interventional Cardiology
Lecture:Pitfalls in Antiplatelet Therapy
Dresden, June 10, 2015

Hannover Heart Fair 2015
Lecture:Which strategies save lives in acute myocardial infarction?
Hannover, May 9, 2015

Atrial fibrillation and thromboembolic events
Lecture:When and with what to anticoagulate in atrial fibrillation?
Munich, May 6, 2015

ICNC Congress: Nuclear Cardiology and CT
Practical experience and side effects of Regadenoson in myocardial radionuclide perfusion imaging in over 2,000 patients in a cardiology practice
Madrid, May 5, 2015

Workshop Medicine and Law: Law and Risks in Interventional Cardiology
Lecture:Pitfalls in Antiplatelet Therapy
Munich, April 29, 2015

Update in Cardiology
Lecture:2014 ESC/EACTS Guidelines in myocardial revascularization: what has changed?
Bucharest, April 18, 2015

ACC 2015
Lecture: No role for GPIIb/IIIa in the contemporary era: guidelines should be revised.
San Diego, March 16, 2015

Internal Medicine Interdisciplinary – Diabetology Without Borders
Chair:Diabetes and Interventional Cardiology Lecture:Diabetes and CHD: When to remain conservative, when interventional or surgical?
Unterschleißheim, February 28, 2015

New Developments in Cardiology and Cardiac Surgery – Case Studies and Overview Lectures
Chair:Focus Coronary Arteries
Munich, January 24, 2015

11th OGN Congress
Lecture:Rapiscan – Experiences in Everyday Nuclear Cardiology Practice
Zell am See, Austria, January 22, 2015

p-c-i live Congress
Symposium: Secondary prevention after ACS – role of DOACs Chair
Munich, December 5, 2014

p-c-i-Live Congress
Scientific Direction
Munich, December 3–5, 2014

2014 – Autumn Meeting and Annual Meeting of the Working Group on Rhythmology of the German Cardiac Society – Heart and Circulation Research e.V.
Discussion Leader
Düsseldorf, October 11, 2014

Continuing education:
Interactive case discussion: Patients with unclear thoracic and/or abdominal complaints: how would you proceed? Speaker
Munich, September 24, 2014

Munich Medical Days:
Lecture:Atrial fibrillation, stroke and myocardial infarction – new paths in antithrombotic therapy Chair
Munich, September 20, 2014

ESC Congress:
Lecture: Take-home message – Coronary artery disease update 2014
Barcelona, August 30, 2014

Rosenheim Cardiology Days:
Lecture: Dual antiplatelet therapy in CHD – current status, duration, with what?
Rosenheim, July 12, 2014

New Aspects of Oral Anticoagulation in the Tension Between Guidelines and Cost-Effectiveness
Lecture: Long-term secondary prophylaxis after ACS with Rivaroxaban? – New guidelines on triple therapy
Dr. Müller Clinic, Munich, July 9, 2014

3rd National TAVI User Meeting (Certificate of Attendance)
Nyon, Switzerland, July 4, 2014

Current Topics in Cardiology in Dialogue:
Lecture:PCI and antithrombotic therapy of acute coronary syndrome – all questions answered?
Cologne, June 25, 2014

Medical Continuing Education Event:
Lecture:Clinical value of ischemia detection to avoid unnecessary cardiac catheterizations and stent implantations
Munich, May 28, 2014

17th Spring Meeting, Heart Center Leipzig:
Conservative and interventional treatment strategies Lecture:When and which antiplatelet inhibitor in STEMI and NSTEMI
Leipzig, May 9, 2014

120th Congress of the German Society of Internal Medicine:
Chair:Ischemia diagnostics in CHD: Myocardial scintigraphy avoids unnecessary cardiac catheterizations and stent implantations Lecture: Clinical value of non-invasive and invasive ischemia detection from a cardiological perspective
Wiesbaden, April 26, 2014

Congress: Heart Update
Lecture: Differentiated antiplatelet therapy after interventional procedures: what to do if surgery becomes necessary (bridging)?
Bremen, March 2014

43rd Annual Meeting of the German Society for Thoracic, Cardiac & Vascular Surgery
Lecture:EACTS/ESC revascularization guidelines
Freiburg, February 9, 2014

Lecture: Dr. Müller Clinic
Presentation of the new CPU and treatment pathways in ACS
Munich, January 29, 2014

p-c-i Live 2013
Congress Direction
Munich, November 28–29, 2013

Continuing education event: Chest Pain Unit – Highlights and Everyday Practice
Lecture:Acute coronary syndrome – always cardiac catheter?
Munich, November 25, 2013

9th Asian Interventional Cardiovascular Therapeutics (AICT 2013)
Faculty Member
Bangkok, Thailand, November 14–16, 2013

Fajadet J, Garcia E, Neumann FJ, Hildick-Smith D, Petronio S, Spence M, Wöhrle J, Zaman A, Elhadad S, Silber S on behalf of the Platinum Plus Trial Investigators
Results of the Primary Endpoint of the Platinum Plus Trial: A Prospective, Randomized, Multi-center Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization in a Population of Unrestricted Patients – 1-Year Results TCT (Transcatheter Cardiovascular Therapeutics)
San Francisco, October 2013
PowerPoint Presentation

Lectures at TCT 2013

• p-c-i live partnership session@TCT
• The Case for Prasugrel
• all lectures

San Francisco, USA, October 27–31, 2013

2013 Autumn and Annual Meeting of the Working Group Electrophysiology of the German Cardiac Society – Heart and Circulation Research:
Chair:Symposium: Interventional therapy of ACS – which patient benefits when from dual antiplatelet therapy?
Dresden, October 11, 2013

Training: New Platelet Inhibitors and New Anticoagulants:
Reduction of ischemic events at the cost of increased bleeding? Practical Recommendations Lecture: Problems from a cardiological perspective
Munich, October 9, 2013

Continuing education event: “The cardiological case”
Lecture:Case 1 Acute coronary syndrome – what do the new guidelines tell us? Interventional revascularization and antithrombotic medication
Munich, September 25, 2013

ESC 2013

• Lecture:Coronary Artery Disease – Update 2013
• Chair:Surgical revascularization: refining the outcomes

Amsterdam, August 31 – September 4, 2013

Symposium: ThromboVision: New Perspectives in Anticoagulation
Lecture: Therapy options in ACS: What should one know today?
Berlin, Estrel Hotel, June 15, 2013

Symposium: Atrial Fibrillation, Stroke and Myocardial Infarction: The new medications: better – or just more expensive?
Lecture: Can we afford to implement current guidelines?
Munich, June 13, 2013

Symposium: TCT Russia and XV Moscow’s International Course on Endovascular Therapies Lectures: Coronary Artery Disease in diabetic patients: Complexities and Clinical Evidence”. Which DES to choose for diabetic patients?
The re-emergence of local drug delivery: drug coated balloons Introduction DES with Biodegradable Polymer
Evidence based device selection (stents, thrombectomy, etc.) for primary PCI POBA, BMS, DES, BVS, DCB: practical guide to coronary device selection in 2013
Moscow, Renaissance Moscow Monarch Centre Hotel, June 8–11, 2013

16th Spring Meeting Heart Center Leipzig Lectures:

• The stent of the future
• Dual antiplatelet therapy during and after ACS – When Clopidogrel? – When Prasugrel? – When Ticagrelor?

Leipzig, May 3, 2013

Hannover Heart Fair 2013 Lectures:

• ACS therapy after hospital from the perspective of the outpatient cardiologist
• Platelet inhibitors in/after ACS: Are the guidelines always practice-oriented?

Hannover, April 27, 2013

Edwards Transcatheter Heart Valve Training Program (Certificate of Completion)
Nyon, Switzerland, April 17/18, 2013

Training: Erlangen Cardio Symposium
Lecture: Interventional revascularization and subsequent platelet inhibition: What do the new guidelines tell us?
Erlangen, Arvena Hotel, March 20, 2013

INDIALIVE 2013:
Moderator:Complex PCI Symposium I Chairperson:Bifurcation
Chennai, India, February 28, 2013

Symposium: JIM – Joint Interventional Meeting Lectures:

• The RESOLUTE Program: today and tomorrow
• Novel stent design and Biomimicry in DES

Live Case Commentator: Live cases from Bonn, Germany
Rome, February 14–15, 2013

Training: Antiplatelet therapy in acute coronary syndrome (ACS)
Lecture: Antiplatelet therapy in ACS: From decision dilemma to rational therapy concept“
Continuing education event of the Ecumenical Association Hospital Location: Elisabeth Hospital
Trier, January 16, 2013

Congress: ICI (Innovations in Cardiovascular Innovations) Lectures:

• Ticagrelor or Prasugrel in ACS?
• Personalized Antiplatelet Therapy

Tel Aviv, December 3 and 4, 2012

p-c-i Live
Congress Direction Congress Opening Welcome Theme Block 4, Part B: Antiplatelet Therapy after Stent or Valve Replacement Moderation Live from all Centers: Live Case Results Report Theme Block 5: Atrial Fibrillation and Stroke Prophylaxis Part A: Pharmaceutical Options and Limits Moderation Multi-City Conference Berlin – Munich – Zurich Moderation Closing Address
Munich, November 29–30, 2012

Heart Days 2012
Master Course Cath Lab Welcome and Introduction to the Course
Munich, November 28, 2012

Prasugrel Investigator Masterclass:
What does the future bring? Chair Lecture: Congress Highlights 2012 FEATHER, TRIPLETT, GENERATIONS
Munich, November 24, 2012

Atrial fibrillation, stroke and myocardial infarction: updates on antithrombotic therapy for GPs and cardiologists Lecture:Antiplatelet therapy after stent implantation: Do we still need Clopidogrel?
Cardiological brunch
Altötting, November 17, 2012

Heart Week 2012
Heart in Danger: Recognizing and Treating Coronary Heart Disease Lecture:Risk factors, symptoms, stable angina pectoris and acute coronary syndrome – the emergency
Munich, November 14, 2012

Acute Coronary Syndrome: From Emergency Diagnosis to Aftercare Scientific Continuing Education Welcome and Introduction
Lecture: Myocardial infarction: All catheters? How to optimize aftercare?
Dr. Müller Clinic Munich, November 6, 2012

Fajadet J, Garcia E, Hildick-Smith D, Petronio S, Silber S, Neumann FJ, Zaman A, Wöhrle J, Spence M, Elhadad S on behalf of the Platinum Plus Trial Investigators
A Prospective, Randomized, Multi-center Trial to Assess the Everolimus-Eluting Stent System (PROMUS Element) for Coronary Revascularization in a Population of Unrestricted Patients: PLATiNUM PLUS – 1-Month Results TCT (Transcatheter Cardiovascular Therapeutics)
Miami, October 2012 Poster Presentation

Acute Coronary Syndrome: From Emergency Diagnosis to Aftercare Lecture:Myocardial infarction: All catheters? How to optimize aftercare?
Munich, October 8, 2012

New Paths in Antithrombotic Therapy: Atrial Fibrillation, Stroke and Myocardial Infarction – Current Guideline-Based Treatment Recommendations for GPs and Cardiologists
Lecture:Antithrombotic therapy: Do we need Clopidogrel?
Bayreuth, September 26, 2012

Symposium: Current Developments in Cardiology and Electrophysiology Chair: a new era of anticoagulation
Lecture: New options in anticoagulation after ACS
Düsseldorf, Intercontinental Hotel, September 15, 2012

Symposium: Atrial Fibrillation, Stroke and Myocardial Infarction: Updates on antithrombotic therapy for GPs and cardiologists
Lecture: Antiplatelet therapy after stent implantation
Weimar, September 12, 2012

Lecture: Cardiology Update for General Practitioners
Kloster Fraueninsel (Chiemsee), July 14, 2012

Symposium: Focus Cardiology Lecture:
Platelet inhibitors and coronary stents: Which stents? How long antiplatelet therapy?
University Hospital Regensburg, July 12, 2012

XXXIV Congresso DA SBHCI 2012
New frontiers – treatment of coronary artery disease with drug-coated balloon Lecture:Valentines Trial I: Is the drug-coated balloon an option to BMS and DES in intra-stent restenosis?
Salvador, Brazil, June 20, 2012

TCT Russia
Chair:Use of DES in Specific Clinical Scenarios Moderator: Thrombus Management in STEMI – MGuard™ Late-Breaking Data Moderator: Emerging Coronary Devices Lecture:Clinical update on Paclitaxel-coated balloon formulations: are there alternatives to iopromide-based coatings?
Moscow, Russia, May 28–30, 2012

118th Congress of the German Society of Internal Medicine:
Lecture:Optimal pharmacological lipid therapy in chronic CHD: the new national guidelines of the Federal Medical Association, the National Association of Statutory Health Insurance Physicians and the Association of the Scientific Medical Societies
Wiesbaden, April 16, 2012

78th Annual Meeting of the German Cardiac Society – Heart and Circulation Research e.V Symposium: 3 Years of Prasugrel – Experiences and Outlook
Lecture: Methodology of large studies on platelet inhibition and consequences for practice
Mannheim, April 11, 2012

Medical Continuing Education Event:
Lecture: Acute Coronary Syndrome: How long which antiplatelet inhibitors? – What must the GP consider?
Munich, March 29, 2012

Symposium: Current Cardiology and Angiology
Lecture: Antiplatelet Therapy in Atrial Fibrillation and ACS in Hospital and Practice
Neuburg Castle on the Kammel, Saturday, March 17, 2012

Third National Course on Percutaneous Cardiovascular Interventions Faculty Member
New Delhi, India, February 24–26, 2012

Symposium: JIM – Joint Interventional Meeting Live Case Commentator, Lectures:

• The use of new ADP inhibitors for treatment of ACS: reasons for choosing Prasugrel
• Performance of the Resolute Zotarolimus-eluting Stent for the Treatment of Total Occlusion

Rome, February 9–11, 2012

New Developments in Cardiology and Cardiac Surgery – Case Studies and Overview Lectures
Lecture: Prasugrel and Ticagrelor – and when still Clopidogrel?
Stiftsklinik Augustinum Munich, January 21, 2012

Acute Coronary Syndrome - what to do?
Current guideline-based treatment recommendations for general practitioners and cardiologists Lecture: Prehospital diagnosis and therapy of acute coronary syndrome today
Frankfurt am Main, December 14, 2011

ICI (Innovations in Cardiovascular Innovations) Presentations:

• The RESOLUTE Global Clinical Program with Focus on Patients with Diabetes Mellitus
• Evolution of Mitsu – Merilimus Eluting Coronary Stent System
• Drug-Eluting Balloons for In-Stent Restenosis after BMS or DES: State-of-the-Art Tel Aviv, December 5 and 6, 2011

p-c-i live
Congress Direction Congress Opening Welcome Session 1: Non-invasive Cardiac Imaging Moderation Evening Symposium 1: Antithrombotic/Antiplatelet Therapy with New Agents: Is measuring individual response to platelet aggregation inhibitors still up to date? Lecture 2 Session 4b: Coronary Revascularizations: Different Concepts for Bifurcations Chair TCT Symposium Highlights from TCT 2011 Moderation Closing Address
München, December 1 and 2, 2011

Acute Coronary Syndrome – what to do? New antithrombotic drugs: which benefit – which cost?
Lecture: Or rather Clopidogrel? And now the Atlas Study… consequences for practice
München, BMW-Welt, November 30, 2011

Hypertension: Heart under Pressure – Development – Detection – Treatment Heart Seminar for Patients, Relatives and Interested Parties
Lecture: Hypertension: detection, definition, causes, proper blood pressure measurement
München, November 19, 2011

TCT 2011, Special Twilight Session
Introduction of p-c-i live Lecture: PCI vs. Bypass Surgery: The European View: State of the Art
San Francisco, USA, November 10, 2011

From Research to Practice: Update Cardiology Workshop
Lecture: Acute Coronary Syndrome: how dangerous is it? what needs to be done? where to refer? optimal aftercare?
Bad Kohlgrub, October 22, 2011

Acute Coronary Syndrome - what to do?
Current guideline-based treatment recommendations for general practitioners and cardiologists Lecture: post-hospital: which long-term therapy is used in practice
Weimar, October 12, 2011

Herbsttagung der Deutschen Gesellschaft für Kardiologie-Herz- und Kreislaufforschung Symposium:
Modern platelet inhibition after ACS-PCI – hysteria or therapeutic necessity?
Presentation: Practical implementation: which agent – for whom – and for how long?
Düsseldorf, October 7, 2011

Training: Acute Coronary Syndrome – what to do?
Lecture: Which long-term therapy is used in practice?
Hannover, Loccumer Hof, September 28, 2011

Chiemgau Cardiology Days 2011 Chair
Lecture: Myocardial revascularization, time for an update? New data from ESC 2011
Gut Ising, September 17, 2011

Focus Cardiology Heart Failure and Acute Coronary Syndrome
Lecture: Acute Coronary Syndrome: prehospital: which immediate measures are necessary?
Regensburg, July 2, 2011

ACS MasterClass Munich:
Lecture: The 2010 ESC Guidelines on Myocardial Revascularization: A Critical Review
München, July 7, 2011

Acute Coronary Syndrome - what to do?
Lecture: post-hospital: which long-term therapy is used in practice?
Essen-Rüttenscheid, June 29, 2011

Training on Fraueninsel
Lecture: Acute Coronary Syndrome - care in general practice – advantages of a fixed combination!
Kloster Fraueninsel am Chiemsee, May 21, 2011

DGIM Symposium of the German Society for General and Family Medicine Barfuß-Physicians versus Fly-Leg Counters
Lecture: Stable CHD – does coronary intervention benefit – and whom? Controversy over the new ESC Guidelines
Wiesbaden, May 2, 2011

XXI Workshop of Interventional Cardiology:
Lecture: The Resolute Clinical Programme: Current Status
Hradec Králové, Czech Republic, April 8, 2011

Kuntz RE, Speiser B, Joyal M, Bonan R, Arseneault A, Neiss G, Cox D, Kirsch M, Laskey W, Suntharalingham M, Wilmer C, Brown C, Schwaibold F, Silber S, von Rottkay P, Fischman D, & Savage M, Pocock S, Abdalla for the Beta-Cath System Trial Investigators
Clinical and Angiographic Outcomes After Use of Sr-90 Beta Radiation for the Treatment of De Novo and Restenotic Coronary Lesions – the BETACATH Trial
ACC (Annual Meeting of the American College of Cardiology) in Orlando, Florida March 2011
ppt presentation

Acute Coronary Syndrome - what to do?
Current guideline-based treatment recommendations for general practitioners and cardiologists Lecture: after hospitalization: which long-term therapy is used in practice?
Berlin, March 30, 2011

Heart Days Training Course Catheter Lab Part 3: PCI Instruments
Moderation Lecture:Drug-eluting Stents and Drug-Eluting Balloons Part 4: PCI – Complex Interventions Lecture: Vein graft including protection systems Part 6: Workshops in rotational format Lecture:Coronary interventions: what is evidence-based?
Essen, March 25, 2011

RSICA Congress:
Plenary Session: “New generation of DES, DEB and Bioabsorbable stents”. Lecture: As an Interventional Cardiologist, which DES would you like to have in your arteries? Plenary Session: Modern Interventional Cardiology and Angiology Lecture:Evolution in management of in-stent-restenosis. DEB.
Moscow, March 21, 2011

Heart Failure in Focus – Diagnostics and Therapy 2011:
Lecture:DMP Module Heart Failure: what is new – what is missing?
Erlangen, March 16, 2011

Heart Failure in Focus – Diagnosis and Therapy 2011
Welcome and Introduction
Munich, March 9, 2011

DINK:
Treatment of acute coronary syndrome in 2011 Lecture:ESC Guidelines on myocardial perfusion – what is new?
Wiesbaden, February 25, 2011

Continuing education event Current Topics in Cardiology – New networking concept of the Passau District Hospital gGmbH
Lecture: A bridge from hypertension to acute coronary syndrome with current pharmacotherapy (DMP recognition)
Pocking, February 24, 2011

Cardiology Update 2011 Revascularisation, ACS, Antithrombotics Satellite Symposium
Lecture: Convincing New Stent Developments
Davos, Switzerland, February 17, 2011

Symposium: JIM – Joint Interventional Meeting Live Case Commentator
Live Cases from Milan, Italy Live Cases from Essen, Germany
Rome, Italy, February 10–11, 2011

15th Symposium for Interventional Cardiology and Angiology LiveCourse 2011
Lecture:Anatomical or functional diagnostics in suspected CHD
Hamburg, February 5, 2011

Acute Coronary Syndrome – what to do?
Lecture:pre-hospital: What immediate measures should the first responder (GP, emergency service etc.) take?
Düsseldorf, February 2, 2011

Quality Circle “Focus Diabetes”
Lecture: Arterial Hypertension – the painless risk
Burghausen, January 27, 2011

11th Cardiology Symposium 2011 Status Quo – Current Trends in Cardiology II. Session: Cardiology – Cardiac Surgery Live transmission from the catheter labs of Sana Clinic Lichtenberg and the hybrid OR of DHZB
Panel III. Session: New Data and Guidelines Under Review Lecture: Why did the Heart Team have to be established?
Berlin, January 22, 2011

ICI Congress
Drug-Eluting Balloons Chair Drug-Eluting Balloons (cont.) Lecture:DIOR in Coronary Intervention Lunch Symposium: MGuard, New Evidence in Acute MI Panel Regulation in the Changing Economic and Ethical Environment Lecture:DES: New Recommendations of the ESC
Tel Aviv, Israel, December 7, 2010

p-c-i live Congress
Munich, December 2–3, 2010

Acute Coronary Syndrome – what to do?
Lecture:pre-hospital: What immediate measures should the first responder (GP, emergency service etc.) take?
Erlangen, November 24, 2010

DGK Autumn Meeting Session of the Conference President:
Imaging in acute chest pain Lecture:Nuclear Medicine Symposium: Dual antiplatelet therapy in patients with ACS and PCI Chair
Nuremberg, October 7, 2010

Acute Coronary Syndrome – what to do?
Lecture:pre-hospital: What immediate measures should the first responder (GP, emergency service etc.) take?
Munich, October 6, 2010

ESC Highlights 2010
Welcome and Moderation Lecture:Latest Guidelines on CHD! ‘What should the GP do – what should be left to the clinic?’
Munich, September 29, 2010

11th International Symposium Düsseldorf Current Developments in Cardiology
Lecture: Latest Guidelines
Düsseldorf, September 17, 2010

Heart Days
Part 1: Current Guidelines (compressed) Moderation Lecture:Current indications for elective cardiac catheterization (ESC 2010) Part 3: PCI Instruments Lecture: Drug-eluting Stents and Drug-eluting Balloons Part 4: PCI – Complex Interventions Lecture: Vein graft including protection systems
Duisburg, September 10, 2010

Lecture:
“Optimal therapy of acute coronary syndrome: between Scylla and Charybdis – How do physicians and patients survive this odyssey?”
Landau, June 23, 2010

Cardiac Catheter Symposium
Lecture: “Confusion in therapy with Clopidogrel and Prasugrel in ACS”
Mühldorf, June 12, 2010

11th Heart Action Weimar
Chair:The cardiac patient with…
Weimar, May 29, 2010

EuroPCR Symposium What do Resolute All Comers Data tell us about the treatment of complex patients and complex lesions?
Chair, Lecture: Challenges in treating complex lesions: What answers does the Resolute All Comers trial provide?
Paris, France, May 27, 2010

EuroPCR Evening Symposium
MGuard – two Years Experience in Acute MI Panel
Paris, France, May 26, 2010

59th ESCVS International Congress in conjunction with the 6th Congress of Update in Cardiology and Cardiovascular Surgery – Heart and Health Foundation of Turkey (HHFT) Lunch Symposium IAIC Session Drug-Eluting Stents: A new paradigm in interventional cardiology Lectures:

• Transferability of data between different drug-eluting stents
• STEMI: Early intervention – Thrombus aspiration

Izmir, Turkey, April 17, 2010

DGIM Pro-Con Session Controversial topics in cardiology (case-based)
Lecture:The Drug-Eluting Stent should be used primarily in coronary revascularization: PRO
Wiesbaden, April 11, 2010

DGK 76th Annual Meeting
Poster Lectures: Risk factors/elderly patients Poster Lecture: Cardiovascular risk profile within an integrated CHD care project – comparison between healthy and diseased Poster Lecture: 10-year risk of myocardial infarction in healthy men – comparison of risk distribution for a current care research project with the prospective cardiovascular Münster Study Poster Lecture: Primary prevention of CHD within a care project – improvement of the 10-year risk for myocardial infarction within the first year of participation Symposium: Paradigm shift in dual antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention Lecture: TRITON-TIMI 38: Which patients benefit particularly, which do not? Free Lectures: Diagnosis and Risk Stratification of Patients with Chest Pain Lecture: The importance of chest pain history for efficient cardiovascular risk stratification of healthy subjects Symposium Innovative Concepts for Coronary Intervention Lecture: “EPC capture stenting” in clinical practice – Results of the e-HEALING Registry in 5,000 patients Hotline III Lecture: Cardiovascular risk profiles in an integrated care project for prevention and therapy of CHD
Mannheim, April 8–10, 2010

ACC Coronary Artery Disease
Panel Discussion
Atlanta, USA, March 14, 2010

Modern Diagnostics and Therapy of Acute Coronary Syndrome (ACS)
Lecture: How much diagnostics are necessary in ACS? What is indispensable, what is useful, and what is superfluous? Always cardiac catheter? Stent vs. Bypass
Neuoetting, March 4, 2010

14th Workshop with Live Demonstrations Medication Accompaniment Therapy in Cardiac Interventions
Session I: Coronary Stent Implantation Lecture:DES follow-up: How long dual antiplatelet therapy? 6 months, 12 monthsor lifelong?
Berlin, February 27, 2010

10th Cardiology Symposium 2010 Status Quo – Current Trends in Cardiology II. Symposium: Target and Actual Determination in Rhythmological and Cardiovascular Therapy of Patients with Heart Failure
Lecture:Guidelines for coronary heart disease – what must one do, what can one do? II. Session Panel: Cardiology – Cardiac Surgery Live
Berlin, January 15–16, 2010